您搜索了: convenia (英语 - 爱沙尼亚语)

convenia
convenia

what is convenia?
mis on convenia?

diluent for convenia
convenia lahusti

how does convenia work?
kuidas convenia toimib?

what is convenia used for?
milleks conveniat kasutatakse?

how has convenia been studied?
kuidas conveniat uuriti?

other information about convenia:
muu teave convenia kohta

eu/ 2/ 06/ 059/ 001 convenia
eu/ 2/ 06/ 059/ 001 convenia

what is the risk associated with convenia?
millised on conveniaga kaasnevad riskid?

what benefit has convenia shown during the studies?
milles seisneb uuringute põhjal convenia kasulikkus?

convenia has the benefit of a long duration of activity.
convenia eeliseks on selle pikaajaline toime.

page 2/ 3 ©emea 2006 why has convenia been approved?
miks convenia heaks kiideti?

convenia 80 mg/ml powder for solution for injection for dogs and cats
convenia 80 mg/ml pulber süstelahuse valmistamiseks koertele ja kassidele

convenia 80 mg/ml powder and solvent for solution for injection for dogs and cats
convenia 80 mg/ml pulber ja lahusti süstelahuse valmistamiseks koertele ja kassidele

in all studies, convenia was as effective in curing the infection as the comparator antibiotic.
convenia oli kõikides uuringutes nakkuste ravimisel sama efektiivne kui võrreldav antibiootikum.

convenia is used in cats to treat skin and soft tissue infections, such as wounds and abscesses.
kassidel kasutatakse conveniat naha ja pehmete kudede nakkuste, näiteks haavade ja mädanike raviks.

the active substance in convenia is cefovecin which belongs to a class of antibiotics called third generation cephalosporins.
convenia toimeaine tsefovetsiin on antibiootikum, mis kuulub kolmanda põlvkonna tsefalosporiinide hulka.

convenia contains cefovecin, an antibiotic which is given by injection (under the skin).
convenia sisaldab tsefovetsiini, mis on (naha alla) süstitav antibiootikum.

the european commission granted a marketing authorisation valid throughout the european union, for convenia to pfizer ltd on 19 june 2006.
euroopa komisjon väljastas convenia müügiloa, mis on kehtiv kogu euroopa liidu territooriumil, ettevõttele pfizer ltd 19. juunil 2006.

convenia is used to treat infections caused by certain specific bacteria (see the spc for further details).
conveniat kasutatakse teatavate bakterite põhjustatud nakkuste raviks (vt lähemalt ravimi omaduste kokkuvõttest).